TargetMol
PF-562271 (besylate) is a potent, ATP-competitive, reversible inhibitor of FAK with IC50 of 1.5 nM, ~10-fold less potent for Pyk2 than FAK and >100-fold selectivity against other protein kinases, except for some CDKs.
More Information
Supplier Page
TargetMol
PF-562271 (besylate) is a potent, ATP-competitive, reversible inhibitor of FAK with IC50 of 1.5 nM, ~10-fold less potent for Pyk2 than FAK and >100-fold selectivity against other protein kinases, except for some CDKs.
More Information
Supplier Page
QNZ
10 mg
| 99.17%
TargetMol
QNZ (EVP4593) is an effective inhibitor of NF-κB activation and TNF-α production. The IC50 of QNZ for NF-κB and TNF-α is11 nM and 7 nM, respectively.
More Information
Supplier Page
QNZ
25 mg
| 99.17%
TargetMol
QNZ (EVP4593) is an effective inhibitor of NF-κB activation and TNF-α production. The IC50 of QNZ for NF-κB and TNF-α is11 nM and 7 nM, respectively.
More Information
Supplier Page
BAPTA-AM
5 mg
| Purity Not Available
TargetMol
BAPTA-AM
50 mg
| Purity Not Available
TargetMol
BAPTA-AM
25 mg
| Purity Not Available
TargetMol
BAPTA-AM
10 mg
| Purity Not Available
TargetMol
QNZ
5 mg
| 99.17%
TargetMol
QNZ (EVP4593) is an effective inhibitor of NF-κB activation and TNF-α production. The IC50 of QNZ for NF-κB and TNF-α is11 nM and 7 nM, respectively.
More Information
Supplier Page
QNZ
50 mg
| 99.17%
TargetMol
QNZ (EVP4593) is an effective inhibitor of NF-κB activation and TNF-α production. The IC50 of QNZ for NF-κB and TNF-α is11 nM and 7 nM, respectively.
More Information
Supplier Page